Babak Azarbal, MD
NPI 1669402863ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· Los Angeles, CA
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (MD) in Los Angeles, California, trained at Tulane University School of Medicine (class of 1998). Their prescriptions cost Medicare Part D more than their services did: $432,922 for 1,963 claims, against $135,498 paid for services in 2024. Edwards Lifesciences Corporation was the largest of 4 companies reporting payments in 2025, $474.87 in all, mostly food and beverage.
Overview
| NPI | 1669402863 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Jul 3, 2006 |
| Last updated in NPPES | Mar 17, 2018 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | A72352 | CA |
| Specialist | 174400000X | A72352 | CA |
| Internal Medicine | 207R00000X | A72352 | CA |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | A72352 | CA |
| Internal Medicine, Interventional Cardiology | 207RI0011X | A72352 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Advanced Heart Failure and Transplant Cardiology (CA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 473 |
|---|---|
| Services billed | 1,407 across 54 procedure codes |
| Paid by Medicare | $135,498 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,963 · 4,402 30-day fills |
|---|---|
| Patients | 268 |
| Total drug cost | $432,922 |
| Generic share | 77% of claims |
Education and affiliations
| Medical school | Tulane University School of Medicine |
|---|---|
| Graduation year | 1998 |
| Medicare specialty | Advanced Heart Failure And Transplant Cardiology |
| Secondary specialties | Internal Medicine |
| Telehealth | Offers telehealth |
Medical group
- Cedars-Sinai Medical Care FoundationWest Hollywood, CA · 1,692 clinicians
Hospital affiliations
- Cedar-Sinai Marina del Rey HospitalMarina Del Rey, CA
- Cedars-Sinai Medical CenterLos Angeles, CA
Industry payments (Open Payments)
- 2025$474.87 · 5 payments from 4 companies
- 2024$17.56 · 1 payment from 1 company
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Edwards Lifesciences Corporation | $246.50 | 2 |
| Boston Scientific Corporation | $170.67 | 1 |
| Recor Medical Inc | $33.86 | 1 |
| Abbott Laboratories | $23.84 | 1 |
What the 2025 payments were for
- Food and Beverage$474.87 · 5 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Los Angeles
- 1427090091
- 1407863756
- 1467548073
- 1134516453
- 1619138872
- 1316988116
- 1821388869
- 1538459276
- 1134396591
- 1144584913
All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in California →